A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
MIT Startup Exchange December 2024 Demo Day
December 11, 2024
Virtual Event